Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation
Abstract Background We report a boy with an unusually late presentation of Farber lipogranulomatosis type l. Case study The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared mu...
Gespeichert in:
Veröffentlicht in: | European journal of paediatric neurology 2011-03, Vol.15 (2), p.171-173 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 173 |
---|---|
container_issue | 2 |
container_start_page | 171 |
container_title | European journal of paediatric neurology |
container_volume | 15 |
creator | Cvitanovic-Sojat, L Juraski, R. Gjergja Sabourdy, F Fensom, A.H Fumic, K Paschke, E Levade, T |
description | Abstract Background We report a boy with an unusually late presentation of Farber lipogranulomatosis type l. Case study The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared much later. The history of the disease, from the first symptoms till his early death, lasted 26.5 months. The neuronal dysfunction accompanied by the rapid neurological deterioration with seizures and myoclonias, rather than the general dystrophy, seemed to limit the duration of disease in our patient and provoked his early death. Diagnosis was confirmed by analysis of ceramide metabolism in cultured fibroblasts and of the ASAH1 gene, which indicated homozygosity for a novel point mutation. Conclusion The deficient activity of acid ceramidase correlated well with poor prognosis of the disease in our boy, in contrast to late appearance of dermal nodules and the subsequent severe clinical course with fatal outcome. Farber lipogranulomatosis should be suspected in children with joint swelling as the first and only symptom of disease. In order to advance our knowledge towards establishing genotype–phenotype correlations in Farber’s disease, detailed analysis of the ASAH1 gene is needed. |
doi_str_mv | 10.1016/j.ejpn.2010.06.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_862784362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1090379810001194</els_id><sourcerecordid>856770574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-8dd328cad3ad5a57a17815a9b1d46cebd98fd46b50e3d5ab20cd0e87ed9cef6b3</originalsourceid><addsrcrecordid>eNqFUsFu1DAUjBCIlsIPcEC-ccrybCdOIiGk1Yq2SCtxKJwtx37bOiR2sJNW4QL_0D_kS3C0hQMHOPlpPDN6ejNZ9pLChgIVb7oNdqPbMEgAiA0Ae5Sd0pKznFEOj9MMDeS8auqT7FmMHQA0BRNPsxMGAhoB_DT7fq5Ci4H0dvTXQbm594OafLSRTMuIhJKfP-7JXk1IxoAR3aQm6x1RzhBUoV-IQTXdEJsgsgs-_SpHWr-QO5tgRZy_xZ7c-MF_W679HMn2antJyTAfjZ5nTw6qj_ji4T3LPp-__7S7zPcfLz7stvtcFwWb8toYzmqtDFemVGWlaFXTUjUtNYXQ2JqmPqSpLQF5IrQMtAGsKzSNxoNo-Vn2-ug7Bv91xjjJwUaNfa8cpq1kLVhVF1yw_zNLUVVQVkVisiNTBx9jwIMcgx1UWCQFuSYkO7kmJNeEJAiZEkqiVw_2czug-SP5HUkivD0SMJ3j1mKQUVt0Go0NqCdpvP23_7u_5Lq3zmrVf8EFY-fn4NKhJZWRSZBXa0fWitDUDkqbgv8Cdmu5mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>856770574</pqid></control><display><type>article</type><title>Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cvitanovic-Sojat, L ; Juraski, R. Gjergja ; Sabourdy, F ; Fensom, A.H ; Fumic, K ; Paschke, E ; Levade, T</creator><creatorcontrib>Cvitanovic-Sojat, L ; Juraski, R. Gjergja ; Sabourdy, F ; Fensom, A.H ; Fumic, K ; Paschke, E ; Levade, T</creatorcontrib><description>Abstract Background We report a boy with an unusually late presentation of Farber lipogranulomatosis type l. Case study The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared much later. The history of the disease, from the first symptoms till his early death, lasted 26.5 months. The neuronal dysfunction accompanied by the rapid neurological deterioration with seizures and myoclonias, rather than the general dystrophy, seemed to limit the duration of disease in our patient and provoked his early death. Diagnosis was confirmed by analysis of ceramide metabolism in cultured fibroblasts and of the ASAH1 gene, which indicated homozygosity for a novel point mutation. Conclusion The deficient activity of acid ceramidase correlated well with poor prognosis of the disease in our boy, in contrast to late appearance of dermal nodules and the subsequent severe clinical course with fatal outcome. Farber lipogranulomatosis should be suspected in children with joint swelling as the first and only symptom of disease. In order to advance our knowledge towards establishing genotype–phenotype correlations in Farber’s disease, detailed analysis of the ASAH1 gene is needed.</description><identifier>ISSN: 1090-3798</identifier><identifier>EISSN: 1532-2130</identifier><identifier>DOI: 10.1016/j.ejpn.2010.06.002</identifier><identifier>PMID: 20609603</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acid ceramidase ; Acid Ceramidase - genetics ; Age of Onset ; Cherry-red spot ; Child, Preschool ; Croatia - ethnology ; Farber Lipogranulomatosis - genetics ; Farber Lipogranulomatosis - pathology ; Farber lipogranulomatosis type 1 ; Fatal Outcome ; Genetic Predisposition to Disease - genetics ; Hoarseness ; Humans ; Joint swelling ; Male ; Mutation - genetics ; Neurology ; Pediatrics ; Subcutaneous nodules</subject><ispartof>European journal of paediatric neurology, 2011-03, Vol.15 (2), p.171-173</ispartof><rights>European Paediatric Neurology Society</rights><rights>2010 European Paediatric Neurology Society</rights><rights>Copyright © 2010 European Paediatric Neurology Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-8dd328cad3ad5a57a17815a9b1d46cebd98fd46b50e3d5ab20cd0e87ed9cef6b3</citedby><cites>FETCH-LOGICAL-c442t-8dd328cad3ad5a57a17815a9b1d46cebd98fd46b50e3d5ab20cd0e87ed9cef6b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1090379810001194$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20609603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cvitanovic-Sojat, L</creatorcontrib><creatorcontrib>Juraski, R. Gjergja</creatorcontrib><creatorcontrib>Sabourdy, F</creatorcontrib><creatorcontrib>Fensom, A.H</creatorcontrib><creatorcontrib>Fumic, K</creatorcontrib><creatorcontrib>Paschke, E</creatorcontrib><creatorcontrib>Levade, T</creatorcontrib><title>Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation</title><title>European journal of paediatric neurology</title><addtitle>Eur J Paediatr Neurol</addtitle><description>Abstract Background We report a boy with an unusually late presentation of Farber lipogranulomatosis type l. Case study The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared much later. The history of the disease, from the first symptoms till his early death, lasted 26.5 months. The neuronal dysfunction accompanied by the rapid neurological deterioration with seizures and myoclonias, rather than the general dystrophy, seemed to limit the duration of disease in our patient and provoked his early death. Diagnosis was confirmed by analysis of ceramide metabolism in cultured fibroblasts and of the ASAH1 gene, which indicated homozygosity for a novel point mutation. Conclusion The deficient activity of acid ceramidase correlated well with poor prognosis of the disease in our boy, in contrast to late appearance of dermal nodules and the subsequent severe clinical course with fatal outcome. Farber lipogranulomatosis should be suspected in children with joint swelling as the first and only symptom of disease. In order to advance our knowledge towards establishing genotype–phenotype correlations in Farber’s disease, detailed analysis of the ASAH1 gene is needed.</description><subject>Acid ceramidase</subject><subject>Acid Ceramidase - genetics</subject><subject>Age of Onset</subject><subject>Cherry-red spot</subject><subject>Child, Preschool</subject><subject>Croatia - ethnology</subject><subject>Farber Lipogranulomatosis - genetics</subject><subject>Farber Lipogranulomatosis - pathology</subject><subject>Farber lipogranulomatosis type 1</subject><subject>Fatal Outcome</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Hoarseness</subject><subject>Humans</subject><subject>Joint swelling</subject><subject>Male</subject><subject>Mutation - genetics</subject><subject>Neurology</subject><subject>Pediatrics</subject><subject>Subcutaneous nodules</subject><issn>1090-3798</issn><issn>1532-2130</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsFu1DAUjBCIlsIPcEC-ccrybCdOIiGk1Yq2SCtxKJwtx37bOiR2sJNW4QL_0D_kS3C0hQMHOPlpPDN6ejNZ9pLChgIVb7oNdqPbMEgAiA0Ae5Sd0pKznFEOj9MMDeS8auqT7FmMHQA0BRNPsxMGAhoB_DT7fq5Ci4H0dvTXQbm594OafLSRTMuIhJKfP-7JXk1IxoAR3aQm6x1RzhBUoV-IQTXdEJsgsgs-_SpHWr-QO5tgRZy_xZ7c-MF_W679HMn2antJyTAfjZ5nTw6qj_ji4T3LPp-__7S7zPcfLz7stvtcFwWb8toYzmqtDFemVGWlaFXTUjUtNYXQ2JqmPqSpLQF5IrQMtAGsKzSNxoNo-Vn2-ug7Bv91xjjJwUaNfa8cpq1kLVhVF1yw_zNLUVVQVkVisiNTBx9jwIMcgx1UWCQFuSYkO7kmJNeEJAiZEkqiVw_2czug-SP5HUkivD0SMJ3j1mKQUVt0Go0NqCdpvP23_7u_5Lq3zmrVf8EFY-fn4NKhJZWRSZBXa0fWitDUDkqbgv8Cdmu5mw</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Cvitanovic-Sojat, L</creator><creator>Juraski, R. Gjergja</creator><creator>Sabourdy, F</creator><creator>Fensom, A.H</creator><creator>Fumic, K</creator><creator>Paschke, E</creator><creator>Levade, T</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20110301</creationdate><title>Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation</title><author>Cvitanovic-Sojat, L ; Juraski, R. Gjergja ; Sabourdy, F ; Fensom, A.H ; Fumic, K ; Paschke, E ; Levade, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-8dd328cad3ad5a57a17815a9b1d46cebd98fd46b50e3d5ab20cd0e87ed9cef6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acid ceramidase</topic><topic>Acid Ceramidase - genetics</topic><topic>Age of Onset</topic><topic>Cherry-red spot</topic><topic>Child, Preschool</topic><topic>Croatia - ethnology</topic><topic>Farber Lipogranulomatosis - genetics</topic><topic>Farber Lipogranulomatosis - pathology</topic><topic>Farber lipogranulomatosis type 1</topic><topic>Fatal Outcome</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Hoarseness</topic><topic>Humans</topic><topic>Joint swelling</topic><topic>Male</topic><topic>Mutation - genetics</topic><topic>Neurology</topic><topic>Pediatrics</topic><topic>Subcutaneous nodules</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cvitanovic-Sojat, L</creatorcontrib><creatorcontrib>Juraski, R. Gjergja</creatorcontrib><creatorcontrib>Sabourdy, F</creatorcontrib><creatorcontrib>Fensom, A.H</creatorcontrib><creatorcontrib>Fumic, K</creatorcontrib><creatorcontrib>Paschke, E</creatorcontrib><creatorcontrib>Levade, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>European journal of paediatric neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cvitanovic-Sojat, L</au><au>Juraski, R. Gjergja</au><au>Sabourdy, F</au><au>Fensom, A.H</au><au>Fumic, K</au><au>Paschke, E</au><au>Levade, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation</atitle><jtitle>European journal of paediatric neurology</jtitle><addtitle>Eur J Paediatr Neurol</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>15</volume><issue>2</issue><spage>171</spage><epage>173</epage><pages>171-173</pages><issn>1090-3798</issn><eissn>1532-2130</eissn><abstract>Abstract Background We report a boy with an unusually late presentation of Farber lipogranulomatosis type l. Case study The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared much later. The history of the disease, from the first symptoms till his early death, lasted 26.5 months. The neuronal dysfunction accompanied by the rapid neurological deterioration with seizures and myoclonias, rather than the general dystrophy, seemed to limit the duration of disease in our patient and provoked his early death. Diagnosis was confirmed by analysis of ceramide metabolism in cultured fibroblasts and of the ASAH1 gene, which indicated homozygosity for a novel point mutation. Conclusion The deficient activity of acid ceramidase correlated well with poor prognosis of the disease in our boy, in contrast to late appearance of dermal nodules and the subsequent severe clinical course with fatal outcome. Farber lipogranulomatosis should be suspected in children with joint swelling as the first and only symptom of disease. In order to advance our knowledge towards establishing genotype–phenotype correlations in Farber’s disease, detailed analysis of the ASAH1 gene is needed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20609603</pmid><doi>10.1016/j.ejpn.2010.06.002</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1090-3798 |
ispartof | European journal of paediatric neurology, 2011-03, Vol.15 (2), p.171-173 |
issn | 1090-3798 1532-2130 |
language | eng |
recordid | cdi_proquest_miscellaneous_862784362 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acid ceramidase Acid Ceramidase - genetics Age of Onset Cherry-red spot Child, Preschool Croatia - ethnology Farber Lipogranulomatosis - genetics Farber Lipogranulomatosis - pathology Farber lipogranulomatosis type 1 Fatal Outcome Genetic Predisposition to Disease - genetics Hoarseness Humans Joint swelling Male Mutation - genetics Neurology Pediatrics Subcutaneous nodules |
title | Farber lipogranulomatosis type 1 – Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T23%3A58%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Farber%20lipogranulomatosis%20type%201%20%E2%80%93%20Late%20presentation%20and%20early%20death%20in%20a%20Croatian%20boy%20with%20a%20novel%20homozygous%20ASAH1%20mutation&rft.jtitle=European%20journal%20of%20paediatric%20neurology&rft.au=Cvitanovic-Sojat,%20L&rft.date=2011-03-01&rft.volume=15&rft.issue=2&rft.spage=171&rft.epage=173&rft.pages=171-173&rft.issn=1090-3798&rft.eissn=1532-2130&rft_id=info:doi/10.1016/j.ejpn.2010.06.002&rft_dat=%3Cproquest_cross%3E856770574%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=856770574&rft_id=info:pmid/20609603&rft_els_id=1_s2_0_S1090379810001194&rfr_iscdi=true |